Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14.11. | Inspire Veterinary Partners GAAP EPS of -$0.38, revenue of $4.05M | 2 | Seeking Alpha | ||
14.11. | INSPIRE VETERINARY PARTNERS, INC.: Inspire Veterinary Partners Reports Third Quarter 2024 Financial Results | 235 | ACCESSWIRE | VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S.... ► Artikel lesen | |
13.11. | INSPIRE VETERINARY PARTNERS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
23.10. | INSPIRE VETERINARY PARTNERS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
22.10. | Inspire Veterinary stock higher as it looks to raise $2.5M through direct offering | 3 | Seeking Alpha | ||
22.10. | INSPIRE VETERINARY PARTNERS, INC.: Inspire Veterinary Partners Announces $2.5 Million Registered Direct Offering of Common Stock | 138 | ACCESSWIRE | VIRGINIA BEACH, VA / ACCESSWIRE / October 22, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S.... ► Artikel lesen | |
17.10. | Aktie von Inspire Veterinary Partners erreicht 52-Wochen-Tief bei 0,23 US-Dollar | 2 | Investing.com Deutsch | ||
INSPIRE VETERINARY PARTNERS Aktie jetzt für 0€ handeln | |||||
17.10. | Inspire Veterinary Partners stock hits 52-week low at $0.23 | 2 | Investing.com | ||
15.10. | Inspire Veterinary Partners adjusts warrant terms | 2 | Investing.com | ||
15.10. | INSPIRE VETERINARY PARTNERS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
30.09. | Inspire Veterinary Partners faces Nasdaq delisting | 3 | Investing.com | ||
30.09. | Inspire Veterinary Partners droht Delisting von der Nasdaq | 1 | Investing.com Deutsch | ||
27.09. | Inspire Veterinary Partners files $100M mixed shelf offering | 3 | Seeking Alpha | ||
26.09. | Inspire Veterinary Partners sells Hawaiian Clinic | 2 | Investing.com | ||
26.09. | Inspire Veterinary Partners verkauft Tierklinik auf Hawaii | 1 | Investing.com Deutsch | ||
26.09. | INSPIRE VETERINARY PARTNERS, INC. - 8-K, Current Report | 5 | SEC Filings | ||
12.09. | (IVP) - Analyzing Inspire Veterinary's Short Interest | 1 | Benzinga.com | ||
27.08. | Inspire Veterinary Partners to acquire Vetsie.ai | 3 | Seeking Alpha | ||
27.08. | Inspire Veterinary Partners eyes acquisition of AI firm Vetsie.ai | 2 | Investing.com | ||
27.08. | INSPIRE VETERINARY PARTNERS, INC.: Inspire Veterinary Partners Announces Non-Binding Acquisition Proposal of Vetsie.ai | 455 | ACCESSWIRE | VIRGINIA BEACH, VA / ACCESSWIRE / August 27, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S.... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 32,820 | +1,89 % | WARBURG RESEARCH stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat das Kursziel für Fresenius von 44 auf 42 Euro gesenkt, aber die Einstufung auf "Buy" belassen. "Nächster Schritt: Revitalisierung",... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 92,70 | 0,00 % | Looking Into PROCEPT BioRobotics' Recent Short Interest | ||
GERRESHEIMER | 69,15 | -1,43 % | Aixtron, Gerresheimer, Hugo Boss, K+S, Lufthansa, Rheinmetall u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
ATRICURE | 36,030 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
CARL ZEISS MEDITEC | 54,75 | -3,78 % | Carl Zeiss Meditec Aktie: Planänderungen erforderlich | Die Carl Zeiss Meditec-Aktie verzeichnete am Handelstag einen deutlichen Kursrückgang. Im XETRA-Handel fiel der Aktienkurs um 2,3 Prozent auf 56,65 Euro, nachdem er bei Börseneröffnung noch bei 58,65... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 49,300 | -0,80 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers nach einer Investorenveranstaltung mit einem Kursziel von 65,90 Euro auf "Overweight" belassen. Die Themen... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 20,790 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2024 Financial Results | Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 41,600 | +1,96 % | DZ BANK stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für FMC von 37 auf 41 Euro angehoben und die Einstufung auf "Halten" belassen. Der Dialyseanbieter habe ein gelungenes Quartal hinter sich... ► Artikel lesen | |
GENEDX | 69,40 | 0,00 % | GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells $8,973,629.96 in Stock | ||
TEMPUS AI | 58,12 | 0,00 % | Cathie Wood's ARK ETFs Adjust Portfolio with Notable Tesla and Tempus AI Stock Trades | ||
NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 11,980 | 0,00 % | Alignment Healthcare announces offering of $330M convertible debt | ||
PROGYNY | 13,980 | 0,00 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
ENDRA LIFE SCIENCES | 5,070 | 0,00 % | ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update | ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months... ► Artikel lesen | |
RXSIGHT | 44,830 | 0,00 % | Rxsight Co-Präsident Ilya Goldshleger verkauft Aktien im Wert von 363.752 US-Dollar |